J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Google Scholar
Right arrow Articles by Schmidt, S.
Right arrow Articles by Derendorf, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, S.
Right arrow Articles by Derendorf, H.

REVIEW/METHODS

Clinical Microdialysis in Skin and Soft Tissues: An Update

Stephan Schmidt, BS, Rebecca Banks, BS, Vipul Kumar, PhD, Kenneth H. Rand, MD and Hartmut Derendorf, PhD, FCP

From the Department of Pharmaceutics, College of Pharmacy (Mr Schmidt, Ms Banks, Dr Kumar, Dr Derendorf), and the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, (Dr Rand) University of Florida, Gainesville, Florida.

Traditionally, plasma or serum drug concentrations have been used for the assessment of bioavailability and bioequivalence. Since in the majority of cases the site of drug action is in the tissue rather than the blood, the use of corresponding free, unbound concentrations in the tissue is a much more meaningful approach. This can become especially important for topical drug administrations, where locally active drug concentrations can significantly exceed free concentrations in plasma. The ability to measure these free concentrations at the site of drug action over time makes microdialysis a very valuable tool for the assessment of bioavailability and bioequivalence. This has been recognized by industry and regulatory authorities, resulting in a recommendation of the microdialysis technique as a tool for bioequivalence determination of topical dermatologic products. The aim of this article is to provide an updated review of the microdialysis technique, its applications in skin and soft tissues, and the resulting impact on clinical drug development.


Key Words: Microdialysisskinsoft tissuespharmacokinetics

Address for correspondence: Hartmut Derendorf, PhD, FCP, Department of Pharmaceutics, College of Pharmacy, Box 100494, University of Florida, Gainesville, FL 32610; e-mail: hartmut{at}cop.ufl.edu.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Clinical Pharmacology